Percutaneous balloon mitral valvuloplasty under neuroprotection: Too Early for Knighthood.

Catheter Cardiovasc Interv

Department of Cardiology, Advanced Cardiac Centre, Post Graduate Institute of Medical Education and Research, Chandigarh, 160 012, India.

Published: November 2016

The case describes the successful percutaneous balloon mitral valvuloplasty under neuroprotection in a patient with severe symptomatic mitral stenosis and persistent left atrial appendage thrombus despite chronic warfarin therapy. Although the procedure was uneventful for any systemic embolism, the limitations of this approach are highlighted with authors still advocating that surgery remains the benchmark treatment for these patients. © 2014 Wiley Periodicals, Inc.

Download full-text PDF

Source
http://dx.doi.org/10.1002/ccd.25421DOI Listing

Publication Analysis

Top Keywords

percutaneous balloon
8
balloon mitral
8
mitral valvuloplasty
8
valvuloplasty neuroprotection
8
neuroprotection early
4
early knighthood
4
knighthood case
4
case describes
4
describes successful
4
successful percutaneous
4

Similar Publications

Background And Rationale: In-stent restenosis (ISR) remains the leading cause of treatment failure following percutaneous coronary intervention (PCI) with contemporary drug-eluting stents. Especially in small caliber coronary arteries, restenosis is common following PCI and represents a treatment challenge. Drug-coated balloons (DCB) are an attractive alternative to stents for treatment of both ISR and small vessel disease.

View Article and Find Full Text PDF

Endoscopic Management of Benign Pancreaticobiliary Disorders.

J Clin Med

January 2025

Division of Gastroenterology and Hepatology, Center for Digestive Health, Virginia Mason, Franciscan Health, Seattle, WA 98101, USA.

Endoscopic management of benign pancreaticobiliary disorders encompasses a range of procedures designed to address complications in gallstone disease, choledocholithiasis, and pancreatic disorders. Acute cholecystitis is typically treated with cholecystectomy or percutaneous drainage (PT-GBD), but for high-risk or future surgical candidates, alternative decompression methods, such as endoscopic transpapillary gallbladder drainage (ETP-GBD), and endoscopic ultrasound (EUS)-guided gallbladder drainage (EUS-GBD), are effective. PT-GBD is associated with significant discomfort as well as variable adverse event rates.

View Article and Find Full Text PDF

True trifurcation disease of the left main coronary artery is a rare situation encountered in clinical practice. To date, there is no evidence for a standardized strategy of percutaneous coronary intervention in this type of lesion. This article describes a novel three-stent strategy using a combination of Triple-Kissing Balloon Crush in both of the side branches.

View Article and Find Full Text PDF

Objective: The gold standard imaging modality for assessing crural arterial disease is digital subtraction angiography (DSA). Using DSA, the operator can estimate the diameter and degree of stenosis and determine the diameter of the balloon. Since these measures are estimates, it allows for interobserver and intraobserver variability.

View Article and Find Full Text PDF

Balloon-assisted percutaneous thrombin injection in a subclavian artery pseudoaneurysm: A case report.

Radiol Case Rep

March 2025

Department of Medical Imaging, King Abdulaziz Medical City, Ministry of National Guard Health Affairs, Jeddah, Saudi Arabia.

Subclavian artery pseudoaneurysm (SAP) is a rare but lethal diagnosis, and an important condition that should be detected and managed imperatively. SAP has been seldom described in the literature, explaining the lack of concrete management guidelines. Herein we present a case study of a 63-year-old man with SAP post a transcatheter aortic valve implantation (TAVI) done 8 days prior to current presentation.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!